Published in

Taylor & Francis, Expert Opinion on Investigational Drugs, 12(26), p. 1341-1355

DOI: 10.1080/13543784.2017.1389895

Links

Tools

Export citation

Search in Google Scholar

Directing the use of DDR kinase inhibitors in cancer treatment

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO